PATENT CLAIM ANALYSIS

Application Number: 15992529
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "649000"]

Abstract:
The present invention relates to a composition of enantiomers of 3,6,7,7a-tetrahydro-1H-pyrrolo[1,5-a]imidazole-2,5-dione and pharmaceutically acceptable solvates or co-crystals thereof in a certain ratio, a pharmaceutical composition comprising said composition, its use as a medicament and the use of the inventive compositions or pharmaceutical compositions in the treatment and/or prevention of a disease or disorder typically and preferably selected from peripheral sensory neuropathy, preferably peripheral neuropathic pain; seizure; depression; or cognitive impairment.

Claim (Index 12):
The method of  claim 9 , wherein the peripheral sensory neuropathy is peripheral sensory neuropathy induced by a chemotherapeutic agent or peripheral sensory neuropathy induced by an antiviral agent.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.47273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12450944', '13166088', '12891280', '13102705', '14291901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7447903410560694
- 35 USC 102 Novelty (BERT): 0.5275627909446695
- Combined Prediction Score: 0.7230675860449294
- Mean Citation Score: 270.29950599999995
- Max Citation Score: 319.89517
- Similarity Product: 243.0616753252364

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test